News

Published on 19 Jun 2024 on Zacks · via Yahoo Finance

Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up


Article preview image

Enzo Biochem, Inc. ENZ delivered a loss per share of 4 cents from continuing operations in the third quarter of fiscal 2024, narrower than the year-ago quarter’s loss of 16 cents per share.

Revenues in Detail

Enzo Biochem’s Life Sciences Products reporting unit operates in one reportable segment, Products.

NYSE.ENZ price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of Enzo Biochem, Inc. ENZ, assigning a ...

Zacks · via Yahoo Finance 19 Jun 2024

Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up

Enzo Biochem, Inc. ENZ delivered a loss per share of 4 cents from continuing operations in the th...

Zacks · via Yahoo Finance 19 Jun 2024

Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years...

Investing in stocks inevitably means buying into some companies that perform poorly. But the long...

Simply Wall St. via Yahoo Finance 14 Mar 2024

Jim Simons Trims Stake in Enzo Biochem Inc

Recent Stock Transaction Overview On December 29, 2023, Renaissance Technologies, led by Jim Simo...

GuruFocus.com via Yahoo Finance 14 Feb 2024

Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)

Laughing Water Capital, an investment management company, released its fourth-quarter 2023 invest...

Insider Monkey via Yahoo Finance 28 Jan 2024

Enzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years...

Generally speaking long term investing is the way to go. But unfortunately, some companies simply...

Simply Wall St. via Yahoo Finance 6 Oct 2023

Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)

Laughing Water Capital, an investment management company, released its second-quarter 2023 invest...

Insider Monkey via Yahoo Finance 19 Jul 2023

Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricing

There wouldn't be many who think Enzo Biochem, Inc.'s (NYSE:ENZ) price-to-sales (or "P/S") ratio ...

Simply Wall St. via Yahoo Finance 8 Jun 2023

Enzo Biochem Insiders Added US$11m Of Stock To Their Holdings \

Over the last year, a good number of insiders have significantly increased their holdings in Enzo...

Simply Wall St. via Yahoo Finance 14 May 2023

Enzo Biochem (NYSE:ENZ) shareholders have endured a 58% loss from investing in the stock five years...

It is a pleasure to report that the Enzo Biochem, Inc. (NYSE:ENZ) is up 66% in the last quarter. ...

Simply Wall St. via Yahoo Finance 17 Apr 2023